
September 18, 2024
Sarama Resources Ltd. (“Sarama” or the “Company”) (ASX:SRR, TSX- V:SWA) is pleased to report that on 18 September 2024, it had completed the issue of shares in part settlement of deferred executive salaries and director fees (the “Compensation Shares” or the “Shares for Debt”) as previously announced in a news release dated 17 July 2024.
The Shares for Debt arrangement comprised the issue of 22,348,980 Chess Depository Instruments (“CDIs”) at a deemed issue price of A$0.02 per CDI, equivalent to A$446,979.60 as detailed in Table 1 below. Each new CDI issued under the Placement will rank equally with existing CDIs on issue and each CDI will represent a beneficial interest in one common share of the Company. The issuance of the Shares for Debt was subject to TSXV and shareholder approval which was obtained at the annual general meeting held on 11 September 2024 (the “Meeting”).

The Compensation Shares and Shares for Debt were issued upon receipt of shareholder approval, as required by the Australian Securities Exchange Listing Rules, at the Meeting. An Appendix 2A was announced to the ASX on 18 September 2024 and provides further detail on the issue of the Compensation Shares and Shares for Debt.
The Share for Debt arrangement will reduce the Company’s liabilities.
The CDIs issued under the Placement are subject to a TSX Venture Exchange (“TSXV”) “hold period” of 4 months and one day from the date of issue of the CDIs.
The Securities have not been and will not be registered under the U.S. Securities Act of 1933, as amended, (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from registration is available. This announcement does not constitute an offer to sell or a solicitation of an offer to buy any of the Securities within the United States or to, or for the account or benefit of, U.S. Persons (as defined under Regulation S under the U.S. Securities Act), nor shall there be any sale of these Securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
Click here for the full ASX Release
This article includes content from Sarama Resources, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
SRR:AU

Sign up to get your FREE
Sarama Resources Investor Kit
and hear about exciting investment opportunities.
- Corporate info
- Insights
- Growth strategies
- Upcoming projects
GET YOUR FREE INVESTOR KIT
INN Article Notification
The Conversation (0)
04 November 2025
Sarama Resources
Promising new gold projects in Western Australia, plus a large fully funded arbitration claim.
Promising new gold projects in Western Australia, plus a large fully funded arbitration claim. Keep Reading...
20 May
Sarama Raises A$1.5m in Private Placement
Sarama Resources (SRR:AU) has announced Sarama Raises A$1.5m in Private PlacementDownload the PDF here. Keep Reading...
18 May
Trading Halt
Sarama Resources (SRR:AU) has announced Trading HaltDownload the PDF here. Keep Reading...
15 May
Q1 2026 Interim Financial Statements
Sarama Resources (SRR:AU) has announced Q1 2026 Interim Financial StatementsDownload the PDF here. Keep Reading...
15 May
Qtly Activities Report - Q1 26 Mgmt's Discussion & Analysis
Sarama Resources (SRR:AU) has announced Qtly Activities Report - Q1 26 Mgmt's Discussion & AnalysisDownload the PDF here. Keep Reading...
17 April
Trading Halt
Sarama Resources (SRR:AU) has announced Trading HaltDownload the PDF here. Keep Reading...
26 May
Brightstar Declares Final Investment Decision for Goldfields Project
CONSTRUCTION OF 1.5MTPA LAVERTON PLANT COMMENCES – FIRST GOLD ON TRACK JUNQ’27
Brightstar Resources Limited (ASX: BTR) (Brightstar or the Company) is pleased to announce that its Board of Directors has approved the Final Investment Decision (FID) for the development of its 100% owned Goldfields Project in Western Australia. HIGHLIGHTSBoard approves Final Investment... Keep Reading...
25 May
Rick Rule: Gold, Silver, Oil, Uranium — Price Triggers, My Strategy Now
Rick Rule, proprietor at Rule Investment Media, outlines key factors affecting the resource sector today, highlighting the impact of the Iran war. He also explains what he's doing with his money right now, saying his portfolio is currently underweight when it comes to sub-$250 million market cap... Keep Reading...
25 May
S&P Global: Mining Sector Facing New Wartime Reality
While gold surged to an unprecedented peak exceeding US$5,500 per ounce in January, with copper and silver following suit, the geopolitical landscape shifted violently on February 28. The outbreak of conflict between the US and Iran effectively severed the Strait of Hormuz, causing daily vessel... Keep Reading...
25 May
Perpetua Resources Secures US$2.9 Billion Loan for Idaho Antimony Project
Perpetua Resources (TSX:PPTA,NASDAQ:PPTA) secured a US$2.9 billion loan from the US Export-Import Bank (EXIM) to fund construction of the Stibnite gold project in Idaho, the country’s only planned domestic source of antimony.The 13-year debt facility includes a US$2.4 billion upfront tranche,... Keep Reading...
22 May
New Break Announces Receipt of DTC Eligibility in the United States
New Break Resources Ltd. (CSE: NBRK) (OTCQB: NBRKF) (FSE: O91) ("New Break" or the "Company") is pleased to announce that its common shares are now eligible for electronic clearing and settlement in the United States through the Depository Trust Company ("DTC"). As a subsidiary of the Depository... Keep Reading...
Latest News

Sign up to get your FREE
Sarama Resources Investor Kit
and hear about exciting investment opportunities.
- Corporate info
- Insights
- Growth strategies
- Upcoming projects
GET YOUR FREE INVESTOR KIT
Interactive Chart
Latest Press Releases
Related News
TOP STOCKS
American Battery4.030.24
Aion Therapeutic0.10-0.01
Cybin Corp2.140.00







